Stoke Therapeutics Inc (STOK) — Cash Flow Reinvestment Rate
Stoke Therapeutics Inc (STOK) has a Cash Flow Reinvestment Rate of 0.10x as of March 2025, reinvesting $13.78 Million (capex $152.00K plus investments $13.63 Million) from operating cash flow of $131.83 Million. Explore Stoke Therapeutics Inc (STOK) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Stoke Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Stoke Therapeutics Inc across 1 annual periods. Also explore Stoke Therapeutics Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Stoke Therapeutics Inc (2025–2025)
Year-by-year capital reinvestment analysis for Stoke Therapeutics Inc. For live market cap and broader valuation context, see STOK market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.10x | $186.81 Million | $45.59 Million | $670.00K | — |